#IgANephropathy
Live, measured metrics for the hashtag #IgANephropathy from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.
Own #iganephropathy
This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.
Day-by-day usage
measured · mastodon.online (Mastodon public tags API) · fetched 2026-07-28 20:50 UTC0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.
Related hashtags
measured · mastodon.online (Mastodon public search API) · fetched 2026-07-28 20:50 UTCNo related tags with measured usage found for #iganephropathy.
Live pulse
measured · mastodon.online (Mastodon tag timeline) · fetched 2026-07-28 20:50 UTCEverything below is measured over the latest 7 public posts (spanning ~5188 hours).
Posting hours (UTC)
Languages: English (6) · German (1)
Avg boosts / post: 0.1
Top of the latest posts
Budesonide for IgA-Nephropathy, Phase 3 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01554-4/fulltext?rss=yes Does the company have the guts to do a head-to-head-trial against regular budesonide? #nephrology #IgANephro
This is the methods section of interest - RASi ‘optimized’ ie the maximum tolerated dose had to be at least 50% of max (😏) and BP < 150/100 Note biopsy timing doesn’t matter Note exclusion for heart failure (Endothelin antagonist specific
Headline result from the #Sparsentan PROTECT trial in #IgANephropathy in #Lancet https://authors.elsevier.com/c/1grIl_3CjG8WAP 1/🧵 Full text link via @Rheault_m Big proteinuria reduction:
Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/iganephropathy